InvestorsHub Logo
Post# of 253062
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: genisi post# 63161

Tuesday, 05/05/2009 1:50:11 AM

Tuesday, May 05, 2009 1:50:11 AM

Post# of 253062
CGRB - CB7630 (Abiraterone Acetate) started phase 3 trial in chemotherapy-naive castration-resistant prostate cancer patients.

http://finance.yahoo.com/news/Cougar-Biotechnology-bw-15066718.html?.v=1
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.